Sponsor

Nykode Therapeutics ASA

Norway Gaustadalleen 21, 0349 Oslo, Norway

About the sponsor

Nykode Therapeutics ASA focuses on solid tumor oncology across locally advanced and metastatic disease settings, with interest in cancers that remain difficult to treat in later stages of progression.

Non-small cell lung carcinoma
Renal cell carcinoma
Urothelial carcinoma
Gastric and gastroesophageal junction cancer

The clinical portfolio also includes triple-negative breast cancer, cervical cancer, anal cancer, and head and neck squamous cell carcinoma.

About Specializations

Nykode Therapeutics ASA runs clinical trials in conditions such as Squamous cell carcinoma of head and neck, among others.

Squamous cell carcinoma of head and neck

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Quick filters

1 clinical trial

Squamous cell carcinoma of head and neck

Recruiting

Registered drugNo placebo

Study on the Safety and Effectiveness of VB10.16 and Pembrolizumab for Patients with HPV16-Positive Head and Neck Cancer

Registered drugNo placebo

Czechia

Participants:18–64 years · 65+ years
Substances:Pembrolizumab
Sponsor:Nykode Therapeutics ASA

Contact Research Centre

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →